Dermapharm Holding SE (FRA:DMP)
32.90
-0.10 (-0.30%)
Last updated: Sep 9, 2025, 9:00 AM CET
Dermapharm Holding SE Revenue
Dermapharm Holding SE had revenue of 275.48M EUR in the quarter ending June 30, 2025, a decrease of -2.93%. This brings the company's revenue in the last twelve months to 1.19B, up 3.86% year-over-year. In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B with 3.89% growth.
Revenue (ttm)
1.19B
Revenue Growth
+3.86%
P/S Ratio
1.49
Revenue / Employee
335.39K
Employees
3,610
Market Cap
1.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.20B | 44.72M | 3.89% |
Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
Dec 31, 2020 | 808.31M | 93.94M | 13.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Rheinmetall AG | 10.67B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Dermapharm Holding SE News
- 15 days ago - Dermapharm's Steady Growth: H1 Stability & Q2 EBITDA Boost - Wallstreet:Online
- 15 days ago - EQS-News: Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter - Wallstreet:Online
- 23 days ago - EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 4 weeks ago - Dermapharm Holding SE: On Track for Growth in Q2 2025! - Wallstreet:Online
- 4 weeks ago - EQS-News: Dermapharm Holding SE remains on projected growth trajectory in Q2 2025 - Wallstreet:Online
- 2 months ago - EQS-DD: Dermapharm Holding SE: Wilhelm Beier, buy - Wallstreet:Online
- 2 months ago - EQS-DD: Dermapharm Holding SE: Dr. Andreas Eberhorn, buy - Wallstreet:Online
- 3 months ago - EQS-DD: Dermapharm Holding SE: Anja Schorn, buy - Wallstreet:Online